- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Aventura Private Wealth LLC Buys $2.14 Million Stake in AbbVie Inc.
The institutional investor added 9,364 shares of the pharmaceutical company to its portfolio.
Mar. 22, 2026 at 7:23am
Got story updates? Submit your updates here. ›
Aventura Private Wealth LLC, an institutional investor, purchased a new position in AbbVie Inc. (NYSE:ABBV) during the fourth quarter, according to a recent SEC filing. The firm acquired 9,364 shares of the pharmaceutical company's stock, valued at approximately $2,140,000. AbbVie now makes up about 0.8% of Aventura Private Wealth LLC's holdings, making it the 23rd largest position in the portfolio.
Why it matters
This investment by Aventura Private Wealth LLC reflects the firm's confidence in AbbVie's long-term growth potential. As a major pharmaceutical company with a diverse product portfolio, AbbVie's performance is closely watched by investors and analysts alike.
The details
According to the SEC filing, Aventura Private Wealth LLC purchased the 9,364 shares of AbbVie during the fourth quarter. This new position represents approximately 0.8% of the firm's total portfolio, making AbbVie its 23rd largest holding.
- Aventura Private Wealth LLC purchased the AbbVie shares during the fourth quarter of 2025.
The players
Aventura Private Wealth LLC
An institutional investment firm that manages a diversified portfolio of securities.
AbbVie Inc.
A global biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and chronic medical conditions.
The takeaway
This investment by Aventura Private Wealth LLC underscores the continued investor interest in AbbVie, a leading pharmaceutical company with a strong product pipeline and diversified revenue streams. The firm's decision to add AbbVie to its portfolio suggests confidence in the company's long-term growth prospects.
